ACCENT THERAPEUTICS
Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, they aim to translate extraordinary science into life-changing therapies for patients.
ACCENT THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.accenttx.com
Total Employee:
11+
Status:
Active
Contact:
(339) 970-7400
Total Funding:
103 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome Wordpress Plugins Global Site Tag
Similar Organizations
RubrYc Therapeutics
RubrYc Therapeutics is a biotechnology company.
Re-Vana Therapeutics
Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.
Caraway Therapeutics
Rheostat Therapeutics is a bio therapeutics company.
Lunac Therapeutics
Lunac Therapeutics is a UK-based drug discovery company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Allero Therapeutics
Allero Therapeutics is a biopharmaceutical company.
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Adrenomed
Adrenomed is a privately-financed, clinical-stage biopharmaceutical company.
Alltrna
Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Aurealis Pharma
Aurealis Pharma is a biopharmaceutical company.
Acerus Pharmaceuticals
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company.
Actimed Therapeutics
Actimed Therapeutics is a clinical stage biopharmaceutical company.
Amryt Pharma
Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.
Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
AnHeart Therapeutics
AnHeart Therapeutics is a developer of innovative pharmaceutical products.
Escient Pharmaceuticals
Escient Pharmaceuticals is a privately held biotechnology company.
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Biocytogen
Biopharmaceutical company.
Bond Biosciences
Bond Biosciences is a biopharmaceutical company
Beckley Canopy Therapeutics
Beckley Canopy Therapeutics is a biopharmaceutical company designed to research cannabis health products.
Thetis Pharmaceuticals
Thetis Pharmaceuticals is a biopharmaceutical company.
Kringle Pharma
Kringle Pharma is a biopharmaceutical company.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
1E Therapeutics
1E Therapeutics is a breakthrough, drug development company.
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
SciClone Pharmaceuticals
SciClone Pharmaceuticals is a pharmaceutical company.
Soleno Therapeutics
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
Sollis Therapeutics
Sollis Therapeutics is a pharmaceutical company developing non-opioid analgesic solutions.
Signia Therapeutics
Signia Therapeutics is an innovative French start-up company.
Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Diatech Pharmacogenetics
Diatech Pharmacogenetics is an Italian Precision Medicine company.
Delix Therapeutics
Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.
Humanetics Corporation
clinical stage pharmaceutical company.
Halia Therapeutics
Halia is a preclinical-stage biopharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
IMVAQ Therapeutics
Imvaq Therapeutics is an innovative cancer immunotherapy company.
Isarna Therapeutics
Isarna Therapeutics is a biotechnology company.
Gerostate Alpha
Gerostate Alpha is a pharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Zelluna Immunotherapy
Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.
Zentera Therapeutics
Zentera Therapeutics is a biopharmaceutical company.
ZWI Therapeutics, Inc.
ZWI Therapeutics is a biotech company developing a new polymer to reduce immunogenicity and aid pharmacokinetics of protein therapeutics.
Zhaoke Ophthalmology Pharmaceutical
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Circadian Therapeutics
Circadian Therapeutics is a Pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cycle Pharmaceuticals
Cycle Pharmaceuticals is a pioneering pharmaceutical company.
Alterity Therapeutics
Alterity Therapeutics has developed a proprietary library of class-leading chemical compounds.
Current Advisors List
Board_member
2020-09-01
Board_member
Board_member
Current Employees Featured
Robert A. Copeland President, CSO & Co-Founder @ Accent Therapeutics
President, CSO & Co-Founder
2017-09-01
Nicole Heifner CFO @ Accent Therapeutics
CFO
2017-09-01
Shakti Narayan Chief Executive Officer @ Accent Therapeutics
Chief Executive Officer
2019-09-01
Ann Boriack-Sjodin Vice President of Molecular Discovery @ Accent Therapeutics
Vice President of Molecular Discovery
2017-10-01
Kenneth Duncan Vice President of Chemistry @ Accent Therapeutics
Vice President of Chemistry
David Brower Vice President and Head of Business Development @ Accent Therapeutics
Vice President and Head of Business Development
Scott Ribich Senior Vice President of Biology @ Accent Therapeutics
Senior Vice President of Biology
2021-12-01
Jamie Wilkinson MEntal Health Therapist @ Accent Therapeutics
MEntal Health Therapist
2018-05-01
Founder
Investors List
Droia Ventures
Droia Ventures investment in Series B - Accent Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Accent Therapeutics
NS Investment
NS Investment investment in Series B - Accent Therapeutics
The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research investment in Series B - Accent Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series B - Accent Therapeutics
The Column Group
The Column Group investment in Series B - Accent Therapeutics
GV
GV investment in Series B - Accent Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series B - Accent Therapeutics
Atlas Venture
Atlas Venture investment in Series A - Accent Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series A - Accent Therapeutics
Official Site Inspections
http://www.accenttx.com Semrush global rank: 4.01 M Semrush visits lastest month: 3.08 K
- Host name: afa7f374f51cc8991.awsglobalaccelerator.com
- IP address: 15.197.167.90
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Accent Therapeutics"
Accent Therapeutics | Translating extraordinary science into life ...
Accent is taking a novel view of cancer – leveraging our industry-leading expertise in RNA-modifying protein (RMPs) biology. We look beyond mutation-specific vulnerabilities to identify …See details»
Accent Therapeutics - Crunchbase Company Profile
Contact Email contactus@accenttx.com. Phone Number (339) 970-7400 Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics.See details»
Accent Therapeutics | Translating extraordinary science …
Our team shares an unwavering commitment to improving health outcomes for patients with cancer and a proven track record of accomplishment. Collectively, among the executive team, scientific advisory board, and board of directors, …See details»
Accent Therapeutics, Inc. - LinkedIn
Accent Therapeutics, Inc. Biotechnology Research Lexington, Massachusetts 5,113 followers Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancerSee details»
Accent Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Accent Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Accent Therapeutics, Inc. Company Overview, Contact Details ...
Jan 23, 2024 AbbVie Inc. invests into Accenttx $75M. RNA specialist Accent Therapeutics has continued a healthy series of funding rounds, raising $75 million in a Series C that was led by …See details»
Become an - accenttx.com
Contactus@accenttx.com. For partnership opportunities: collaborations@accenttx.com. We’re proud to be making impactful changes to decrease the environmental footprint of our research by achieving “Green …See details»
Accent Therapeutics, Inc. Information - RocketReach
Accenttx.com; 2 617679XXXX; 508380XXXX; View Similar People. Related Companies Keros Therapeutics. 160 Fractyl Health. 114 $5m Hemanext. 57 $7.7m KSQ Therapeutics, Inc. 104 …See details»
Accent Therapeutics - Overview, News & Similar companies
Mar 21, 2024 Accent Therapeutics Presents Data Supporting Two Lead Programs at AACR 2024 Annual Meeting Robert A. Copeland, Chief Scientific Officer, to provide major …See details»
Accent Therapeutics - Work in biotech
Accent Therapeutics is pioneering the field of epitranscriptomics to develop precision cancer therapies. Epitranscriptomics refers to a collection of RNA-modifying proteins (RMPs) that …See details»
Accent Therapeutics Announces Company Launch with …
May 18, 2018 For more information, please visit www.accenttx.com. Contacts. Ten Bridge Communications Tom Donovan, 857-559-3397 tom@tenbridgecommunications.com. Release Summary.See details»
Accent Therapeutics to Present Data Supporting DHX9 and KIF18A …
Mar 21, 2024 For more information on Accent's mission to translate extraordinary science into life-changing therapeutics for patients living with cancer, visit www.accenttx.com or follow us …See details»
Accent Therapeutics | Translating extraordinary science into life ...
Jacqueline Wheeler joined Accent in 2017 as Executive Assistant and Office Manager to bring organizational leadership and support to the company. Prior to Accent, Jacquie served as …See details»
Accent Therapeutics - VentureRadar
Similar Companies: Arrakis Therapeutics USA Privately Held Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly …See details»
Robert A. Copeland - Google Scholar
President & CSO, Accent Therapeutics, Inc. - Cited by 35,210 - drug discovery - cancer - biochemistry - enzymology - biotechnologySee details»
Accent Therapeutics | Translating extraordinary science into life ...
Oct 24, 2024 For more information on Accent’s mission to translate extraordinary science into life-changing therapeutics for patients living with cancer, visit www.accenttx.com or follow us …See details»
Accent Therapeutics Announces $75 Million Series C Financing to …
Jan 23, 2024 For more information on Accent's mission to translate extraordinary science into life-changing therapeutics for patients living with cancer, visit www.accenttx.com or follow us …See details»
Accent Therapeutics Presents Data Supporting DHX9 Inhibition as …
Apr 16, 2023 The abstract is available online as part of the annual meeting's Proceedings supplement in AACR's journal, Cancer Research, and the presentation will be archived on the …See details»
Accent Therapeutics, Inc. (Accent Therapeutics, Inc.) - 药物管线_专 …
了解Accent Therapeutics, Inc. (Accent Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 25篇新闻和120篇文献，疾病领域:肿瘤，内分泌与代谢疾病，血液及淋 …See details»
Accent Therapeutics | Translating extraordinary science into life ...
For more information on Accent’s mission to translate extraordinary science into life-changing therapeutics for patients living with cancer, visit www.accenttx.com or follow us on LinkedIn. …See details»